Hideki Furuya

3PUBLICATIONS
44CO-AUTHORS
Predictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 30, 2026
Neoadjuvant olaparib and pembrolizumab combination therapy in the treatment of patients with HRD-positive advanced ovarian cancer: A pilot study.

|Mar 07, 2025
CZT-based photon-counting-detector CT with deep-learning reconstruction: image quality and diagnostic confidence for lung tumor assessment.

Tomoaki Sasaki, Hirofumi Kuno, Keiichi Nomura

|Oct 25, 2024
Efficacy, Safety, and Influence on the Tumor Microenvironment of Neoadjuvant Pembrolizumab plus Ramucirumab for PD-L1-Positive NSCLC: A Phase II Trial (EAST ENERGY).

Keiju Aokage, Shohei Koyama, Shogo Kumagai

Pageof 1

Frequent Collaborators

2 joint publications

Masashi Wakabayashi

2 joint publications

Genichiro Ishii

2 joint publications

Tetsuro Taki

2 joint publications

Joji Samejima